P

    P3 Health Partners Inc (PIII)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • NASDAQ

    $9.06
    -0.16 (-1.74%)

    Market Cap: $1.84B

    Last updated: Sep 01, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    57%(12/21)
    Avg Surprise
    +0.43%
    Streak
    2 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-2.77
    Range$-3.36 - $-2.17
    2 analysts
    EPS RevisionsNo revisions (7d)No revisions (30d)
    EPS Estimate Drift
    90d ago$-9.37-238.9%
    60d ago$-9.37-238.9%
    30d ago$0.00+100.0%
    7d ago$-1.54+44.3%
    Current$-2.77
    Revenue Consensus
    $385M
    Range$385M - $385M
    2 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-6.67
    Range$-6.67 - $-6.67
    1 analysts
    Revenue Consensus
    $397M
    Range$389M - $406M
    2 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-6.67---
    Sep 26EST
    		-$-2.77---
    Jun 26
    Reported Aug 10
    		$-0.63N/A+66.67%Beat+89.9%
    Mar 26
    Reported May 14
    		$0.32N/A+109.14%Beat+105.1%
    Dec 25
    Reported Mar 26
    		$-23.02$-9.46-143.21%Miss-6294.4%
    Sep 25
    Reported Nov 14
    		$-9.67$-6.04-60.10%Miss+33.3%
    Jun 25
    Reported Aug 14
    		$-6.23$-4.30-44.88%Miss-38.4%
    Mar 25
    Reported May 15
    		$-6.28$5.00-225.60%Miss+21.5%
    Dec 24
    Reported Mar 27
    		$-0.36$-0.11-227.27%Miss-63.6%
    Sep 24
    Reported Nov 12
    		$-14.50$-1.87-675.40%Miss-141.7%
    Jun 24
    Reported Aug 7
    		$-4.50$-4.83+6.83%Beat+0.0%
    Mar 24
    Reported May 8
    		$-8.00$-6.37-25.59%Miss-3536.4%
    Dec 23
    Reported Mar 28
    		$-0.22$-0.11-100.00%Miss-100.0%
    Sep 23
    Reported Nov 8
    		$-6.00$-11.00+45.45%Beat+55.6%
    Jun 23
    Reported Aug 7
    		$-4.50$-6.50+30.77%Beat-2042.9%
    Mar 23
    Reported May 10
    		$-0.22N/A+67.16%Beat+38.9%
    Dec 22
    Reported Mar 31
    		$444.11$-45.50+1076.07%Beat+888320.0%
    Sep 22
    Reported Nov 14
    		$-13.50$-9.00-50.00%Miss-10284.6%
    Jun 22
    Reported Aug 31
    		$-0.21$-0.23+8.70%Beat+36.4%
    Mar 22
    Reported Apr 25
    		$-0.36$-0.36+0.00%Beat-400.0%
    Dec 21
    Reported Jan 7
    		$-0.05N/A+79.17%Beat-
    Sep 21
    Reported Dec 9
    		$-0.13N/A+71.11%Beat-
    Jun 21
    Reported Aug 19
    		$-0.33$-0.33+0.00%Beat-
    Mar 21
    Reported Apr 6
    		$0.12$0.00N/ABeat-

    Key Metrics

    Valuation
    P/E Ratio-0.27EV/EBITDA-1.86x
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin-6.55%Operating Margin10.70%
    ROE-192.60%ROIC-82.39%
    Financial Health
    Debt/Equity1.67xInterest Coverage-2.74x
    Current Ratio0.46xQuick Ratio0.46x
    Trading Statistics
    Beta1.64Avg Volume65.72K
    52-Week High$16.8952-Week Low$1.52

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$9.96
    SMA 20$10.59
    SMA 50$10.56
    SMA 200$6.22
    EMA 10$9.86
    EMA 20$10.21
    EMA 50$10.18
    EMA 200$7.91

    MACD

    Line: -0.33Signal: -0.13Hist: -0.20

    ADX

    ADX: 14.4+DI: 15.5-DI: 27.7

    Aroon & PSAR

    Aroon Up40.0
    Aroon Down96.0
    PSAR$12.64

    Bollinger Bands

    Upper Band$12.51
    Lower Band$8.66
    %B Position3637%(Upper)
    Band Width0.10

    RSI (14-Day)

    Neutral
    37.0

    Momentum Oscillators

    Stoch %K6.1
    Stoch %D8.2
    Williams %R-92.5
    ROC (10d)-14.3%
    Momentum-1.51
    CCI (20d)-147.6
    MFI (14d)5.6

    Volatility Measures

    ATR (14d)$0.84(9.3%)
    StdDev (20d)0.96
    Hist Vol72.9%(High)

    Volume Flow

    VWAP$9.01
    OBV61.5M
    AD Line24.1B
    CMF (20d)0.052

    Volume Metrics

    Avg Vol (20d)68.0K
    Vol Ratio0.1x(Low)
    VWMA (20d)$11.86

    Pivot Points

    R3$10.72
    R2$10.23
    R1$9.73
    Pivot Point$9.24
    S1$8.73
    S2$8.24
    S3$7.74

    Advanced Oscillators

    TSI-11.26
    Ultimate Osc46.3
    KST-33.08

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$386.38M$386.39M$384.81M$345.25M$355.79M$373.23M$329.31M$362.12M$379.16M$388.49M$346.86M$288.35M
    Cost of Revenue$0$0$447.05M$0$0$0$768.77M$0$0$0$389.31M$0
    Gross Profit$386.38M$386.39M$384.81M$345.25M$355.79M$373.23M$329.31M$362.12M$379.16M$388.49M$346.86M$288.35M
    Operating Expenses$345.15M$378.15M$538.68M$389.48M$389.91M$411.31M$417.46M$469.11M$410.49M$432.32M$411.12M$322.17M
    R&D$0$0$0$0$0$0$0$0$0$0$0$0
    SG&A$32.39M$25.54M$35.88M$22.14M$23.45M$25.00M$25.08M$27.22M$26.61M$27.40M$24.43M$33.06M
    Operating Income$41.23M$8.24M$-153,866,000$-44,223,000$-34,124,000$-38,088,000$-88,146,000$-106,990,000$-31,334,000$-43,831,000$-64,260,000$-33,820,000
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$7.86M$16.77M$15.64M$20.53M$10.14M$8.72M$39.70M$5.65M$5.44M$4.26M$4.05M$4.00M
    Income Before Tax$16.92M$-7,957,000$-166,754,000$-69,450,000$-41,684,000$-43,173,000$-139,266,000$-106,455,000$-27,806,000$-47,534,000$-67,340,000$-36,877,000
    Income Tax Expense$1.26M$-10,997,000$-1,040,000$11,000$1.98M$1.07M$2.59M$-3,605,000$968,000$2.07M$1.77M$412,000
    Net Income$15.65M$3.04M$-75,519,000$-69,461,000$-43,665,000$-44,246,000$-141,856,000$-102,850,000$-28,774,000$-49,606,000$-69,107,000$-37,289,000
    EBITDA$46.42M$32.69M$-130,122,000$-16,909,000$-10,385,000$-13,065,000$-66,608,000$-79,031,000$-628,000$-21,879,000$-41,593,000$-11,089,000
    EBIT$24.78M$8.81M$-151,117,000$-48,923,000$-31,539,000$-34,448,000$-99,409,000$-100,808,000$-22,370,000$-43,278,000$-63,294,000$-32,875,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about PIII

    News

    US$18.00 - That's What Analysts Think P3 Health Partners Inc. (NASDAQ:PIII) Is Worth After These Results

    P3 Health Partners Inc. recently released solid second-quarter results, exceeding analyst revenue forecasts. Despite expectations of increased losses in 2026, analysts have raised their price target to US$18.00, suggesting confidence in the company's long-term intrinsic value. The company's revenue growth is also projected to outpace the wider industry, even with a forecasted slowdown from historical rates.

    Sahm•8/13/26•
    Bullish

    Hudson Vegas Investment Spv, L Sells 50,000 Shares of P3 Health Partners (NASDAQ:PIII) Stock

    Hudson Vegas Investment Spv, L sold 50,000 shares of P3 Health Partners (NASDAQ:PIII) stock for $824,000, reducing its stake by over 50%. The sale occurred on August 10th at an average price of $16.48 per share. Despite the sale, P3 Health Partners reported better-than-expected quarterly results, though its stock dipped by 5.5% on Wednesday.

    MarketBeat•8/12/26•
    Somewhat-Bearish

    P3 Health Partners (PIII) holder Hudson Vegas updates 17.5% stake and recent share sales

    Hudson Vegas Investment SPV, LLC has amended its Schedule 13D filing for P3 Health Partners Inc. (PIII), reporting a beneficial ownership of 17.5%, or 829,651 shares, of Class A Common Stock. This update follows a 1-for-50 reverse stock split and includes details of recent share sales on August 10, 2026, where Hudson Vegas sold multiple tranches of Class A shares at weighted average prices between $13.38 and $16.86 per share. The filing also notes the redemption of 50,000 P3 LLC Units for Class A shares and the cancellation of an equal number of Class V shares on June 10, 2026, and the dismissal of the Delaware Action on August 22, 2024.

    Stock Titan•8/12/26•
    Neutral

    Hudson Vegas Investment SPV Completely Divests P3 Health Partners Shares

    Hudson Vegas Investment SPV, LLC, along with Hudson Vegas Investment Manager, LLC and Daniel Straus, fully divested their direct holdings of P3 Health Partners Inc. (NASDAQ:PIII) Class A Common Stock on August 10, 2026. The sale involved 50,000 shares across three tranches at weighted average prices ranging from $13.38 to $16.86, reducing their direct beneficial ownership to zero. All three entities were identified as 10% owners of P3 Health Partners Inc.

    Kalkine Media•8/12/26•
    Bearish

    P3 Health Partners Inc. - Class A Common Stock (NQ: PIII

    This page provides news and financial information for P3 Health Partners Inc. (Nasdaq: PIII). It lists a series of press releases from the company, primarily detailing earnings announcements, conference participations, and scheduling of financial results releases extending from August 2026 back to August 2024. The stock price was 11.19, down 4.28% as of 3:33 PM EDT, August 13, 2026.

    FinancialContent•8/12/26•
    Neutral

    Frequently Asked Questions About PIII

    Does PIII pay dividends?
    P3 Health Partners Inc (PIII) does not currently pay a regular dividend.
    What is PIII's market cap?
    P3 Health Partners Inc (PIII) has a market capitalization of $1.84B with a current stock price of $9.06.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In